Finding novel treatments rapidly: the ARUK Drug Discovery Alliance
Synapse loss and cognitive decline in ALS: a common feature with Alzheimer’s?
Microglial activation, inflammation and innate immunity in Alzheimer’s disease
What are the benefits of collaborating with the Drug Discovery Institute?
L435F mutations and Alzheimer’s disease